Follow
Yuri Bukhtiyarov
Yuri Bukhtiyarov
Claim Therapeutics
Verified email at claimtx.com - Homepage
Title
Cited by
Cited by
Year
Photoreactive analogues of prenyl diphosphates as inhibitors and probes of human protein farnesyltransferase and geranylgeranyltransferase type I
YE Bukhtiyarov, CA Omer, CM Allen
Journal of Biological Chemistry 270 (32), 19035-19040, 1995
731995
Structure-based design and synthesis of 1, 3-oxazinan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase type 1
Z Xu, CM Tice, W Zhao, S Cacatian, YJ Ye, SB Singh, P Lindblom, ...
Journal of medicinal chemistry 54 (17), 6050-6062, 2011
452011
Discovery of VTP-27999, an alkyl amine renin inhibitor with potential for clinical utility
L Jia, RD Simpson, J Yuan, Z Xu, W Zhao, S Cacatian, CM Tice, J Guo, ...
ACS Medicinal Chemistry Letters 2 (10), 747-751, 2011
412011
Three-dimensional placement of the conserved 530 loop of 16 S rRNA and of its neighboring components in the 30 S subunit
R Wang, RW Alexander, M VanLoock, S Vladimirov, Y Bukhtiyarov, ...
Journal of molecular biology 286 (2), 521-540, 1999
401999
Spirocyclic ureas: Orally bioavailable 11β-HSD1 inhibitors identified by computer-aided drug design
CM Tice, W Zhao, Z Xu, ST Cacatian, RD Simpson, YJ Ye, SB Singh, ...
Bioorganic & medicinal chemistry letters 20 (3), 881-886, 2010
322010
Discovery of a novel, orally efficacious liver X receptor (LXR) β agonist
Y Zheng, L Zhuang, KY Fan, CM Tice, W Zhao, C Dong, SD Lotesta, ...
Journal of Medicinal Chemistry 59 (7), 3264-3271, 2016
302016
Regulation of sphingomyelin phosphodiesterase acid-like 3A gene (SMPDL3A) by liver X receptors
PB Noto, Y Bukhtiyarov, M Shi, BM McKeever, GM McGeehan, DS Lala
Molecular pharmacology 82 (4), 719-727, 2012
282012
Identification of spirooxindole and dibenzoxazepine motifs as potent mineralocorticoid receptor antagonists
SD Lotesta, AP Marcus, Y Zheng, K Leftheris, PB Noto, S Meng, ...
Bioorganic & Medicinal Chemistry 24 (6), 1384-1391, 2016
262016
Design and optimization of renin inhibitors: Orally bioavailable alkyl amines
CM Tice, Z Xu, J Yuan, RD Simpson, ST Cacatian, PT Flaherty, W Zhao, ...
Bioorganic & medicinal chemistry letters 19 (13), 3541-3545, 2009
232009
Optimization of orally bioavailable alkyl amine renin inhibitors
Z Xu, S Cacatian, J Yuan, RD Simpson, L Jia, W Zhao, CM Tice, ...
Bioorganic & medicinal chemistry letters 20 (2), 694-699, 2010
222010
Discovery of BI 135585, an in vivo efficacious oxazinanone-based 11β hydroxysteroid dehydrogenase type 1 inhibitor
L Zhuang, CM Tice, Z Xu, W Zhao, S Cacatian, YJ Ye, SB Singh, ...
Bioorganic & Medicinal Chemistry 25 (14), 3649-3657, 2017
192017
Inhibitors of β-secretase
Y Bukhtiyarov, S Cacatian, LW Dillard, C Dorner-Ciossek, K Fuchs, L Jia, ...
US Patent 8,981,112, 2015
192015
Identification of inhibitors of bacterial transcription/translation machinery utilizing a miniaturized 1536-well format screen
I Kariv, H Cao, PD Marvil, EV Bobkova, YE Bukhtiyarov, YP Yan, U Patel, ...
Journal of Biomolecular Screening 6 (4), 233-243, 2001
182001
Discovery and optimization of adamantyl carbamate inhibitors of 11β-HSD1
CM Tice, W Zhao, PM Krosky, BA Kruk, J Berbaum, JA Johnson, ...
Bioorganic & medicinal chemistry letters 20 (22), 6725-6729, 2010
152010
Solubilization and Characterization of Dehydrodolichy Diphosphate Synthase from the Yeast Saccharomoyces Carlsbergensis
YE Bukhtiyarov, YA Shabalin, IS Kulaev
The Journal of Biochemistry 113 (6), 721-728, 1993
131993
Biphenyl/diphenyl ether renin inhibitors: Filling the S1 pocket of renin via the S3 pocket
J Yuan, RD Simpson, W Zhao, CM Tice, Z Xu, S Cacatian, L Jia, ...
Bioorganic & medicinal chemistry letters 21 (16), 4836-4843, 2011
122011
Brain penetrant liver X receptor (LXR) modulators based on a 2, 4, 5, 6-tetrahydropyrrolo [3, 4-c] pyrazole core
CM Tice, PB Noto, KY Fan, W Zhao, SD Lotesta, C Dong, AP Marcus, ...
Bioorganic & Medicinal Chemistry Letters 26 (20), 5044-5050, 2016
102016
Purification and characterization of recombinant human renin for X-ray crystallization studies
Z Wu, MG Cappiello, BB Scott, Y Bukhtiyarov, GM McGeehan
BMC biochemistry 9, 1-7, 2008
102008
In vitro and in vivo assessment of the potential of supersaturation to enhance the absorption of poorly soluble basic drugs
J Li, Y Bukhtiyarov, N Spivey, C Force, C Hidalgo, Y Huang, AJ Owen, ...
Journal of Pharmaceutical Innovation 15, 591-602, 2020
92020
Safety, tolerability, pharmacokinetics and pharmacodynamics of VTP-43742, a RORγt inhibitor, in normal healthy volunteers
GM McGeehan, SA Palmer, CC Bryson, Y Zhao, M Shi, KK Lipinski, ...
The Journal of Immunology 196 (1_Supplement), 71.4-71.4, 2016
72016
The system can't perform the operation now. Try again later.
Articles 1–20